173 related articles for article (PubMed ID: 9264101)
1. NMDA receptor complex blockade by oral administration of magnesium: comparison with MK-801.
Decollogne S; Tomas A; Lecerf C; Adamowicz E; Seman M
Pharmacol Biochem Behav; 1997 Sep; 58(1):261-8. PubMed ID: 9264101
[TBL] [Abstract][Full Text] [Related]
2. Recovery of NMDA receptor currents from MK-801 blockade is accelerated by Mg2+ and memantine under conditions of agonist exposure.
McKay S; Bengtson CP; Bading H; Wyllie DJ; Hardingham GE
Neuropharmacology; 2013 Nov; 74():119-25. PubMed ID: 23402996
[TBL] [Abstract][Full Text] [Related]
3. NMDA/glutamate mechanism of antidepressant-like action of magnesium in forced swim test in mice.
Poleszak E; Wlaź P; Kedzierska E; Nieoczym D; Wróbel A; Fidecka S; Pilc A; Nowak G
Pharmacol Biochem Behav; 2007 Dec; 88(2):158-64. PubMed ID: 17825400
[TBL] [Abstract][Full Text] [Related]
4. Behavioral evidence for modulation by sigma ligands of (+)MK-801-induced hyperlocomotion in monoamine-depleted mice.
Okuyama S; Imagawa Y; Tomisawa K
Neuropharmacology; 1996 Apr; 35(4):467-74. PubMed ID: 8793909
[TBL] [Abstract][Full Text] [Related]
5. Effect of the glycine/NMDA receptor partial agonist, D-cycloserine, on seizure threshold and some pharmacodynamic effects of MK-801 in mice.
Wlaź P; Baran H; Löscher W
Eur J Pharmacol; 1994 May; 257(3):217-25. PubMed ID: 8088343
[TBL] [Abstract][Full Text] [Related]
6. NMDA receptors are involved in the antidepressant-like effects of capsaicin following amphetamine withdrawal in male mice.
Amiri S; Alijanpour S; Tirgar F; Haj-Mirzaian A; Amini-Khoei H; Rahimi-Balaei M; Rastegar M; Ghaderi M; Ghazi-Khansari M; Zarrindast MR
Neuroscience; 2016 Aug; 329():122-33. PubMed ID: 27167081
[TBL] [Abstract][Full Text] [Related]
7. NMDA receptor antagonists augment antidepressant-like effects of lithium in the mouse forced swimming test.
Ghasemi M; Raza M; Dehpour AR
J Psychopharmacol; 2010 Apr; 24(4):585-94. PubMed ID: 19351802
[TBL] [Abstract][Full Text] [Related]
8. Involvement of N-methyl-D-aspartate (NMDA) receptors in noncompetitive NMDA receptor antagonist-induced hyperlocomotion in mice.
Irifune M; Shimizu T; Nomoto M; Fukuda T
Pharmacol Biochem Behav; 1995; 51(2-3):291-6. PubMed ID: 7667342
[TBL] [Abstract][Full Text] [Related]
9. Modulation of cholestasis-induced antinociception in rats by two NMDA receptor antagonists: MK-801 and magnesium sulfate.
Hasanein P; Parviz M; Keshavarz M; Javanmardi K; Allahtavakoli M; Ghaseminejad M
Eur J Pharmacol; 2007 Jan; 554(2-3):123-7. PubMed ID: 17107671
[TBL] [Abstract][Full Text] [Related]
10. Motor activation in short- and long-term reserpinized mice: role of N-methyl-D-aspartate, dopamine D1 and dopamine D2 receptors.
Ferré S; Giménez-Llort L; Artigas F; Martínez E
Eur J Pharmacol; 1994 Apr; 255(1-3):203-13. PubMed ID: 7913043
[TBL] [Abstract][Full Text] [Related]
11. Chronic treatment with caffeine blunts the hyperlocomotor but not cognitive effects of the N-methyl-D-aspartate receptor antagonist MK-801 in mice.
Dall'Igna OP; Da Silva AL; Dietrich MO; Hoffmann A; de Oliveira RV; Souza DO; Lara DR
Psychopharmacology (Berl); 2003 Mar; 166(3):258-63. PubMed ID: 12589526
[TBL] [Abstract][Full Text] [Related]
12. Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists.
Bespalov A; Dravolina O; Belozertseva I; Adamcio B; Zvartau E
Behav Pharmacol; 2006 Jun; 17(4):295-302. PubMed ID: 16914947
[TBL] [Abstract][Full Text] [Related]
13. MK-801 and enantiomers: potential antidepressants or false positives in classical screening models?
Panconi E; Roux J; Altenbaumer M; Hampe S; Porsolt RD
Pharmacol Biochem Behav; 1993 Sep; 46(1):15-20. PubMed ID: 8255906
[TBL] [Abstract][Full Text] [Related]
14. Opioid/NMDA receptors blockade reverses the depressant-like behavior of foot shock stress in the mouse forced swimming test.
Haj-Mirzaian A; Ostadhadi S; Kordjazy N; Dehpour AR; Ejtemaei Mehr S
Eur J Pharmacol; 2014 Jul; 735():26-31. PubMed ID: 24726844
[TBL] [Abstract][Full Text] [Related]
15. Antidepressant-like effect of lead in adult mice.
Mantovani M; Matteussi AS; Rodrigues AL
Braz J Med Biol Res; 1999 Dec; 32(12):1555-60. PubMed ID: 10585640
[TBL] [Abstract][Full Text] [Related]
16. Anticonvulsant and behavioral profile of L-701,324, a potent, orally active antagonist at the glycine modulatory site on the N-methyl-D-aspartate receptor complex.
Bristow LJ; Hutson PH; Kulagowski JJ; Leeson PD; Matheson S; Murray F; Rathbone D; Saywell KL; Thorn L; Watt AP; Tricklebank MD
J Pharmacol Exp Ther; 1996 Nov; 279(2):492-501. PubMed ID: 8930150
[TBL] [Abstract][Full Text] [Related]
17. Paradoxical effects of very low dose MK-801.
Tang Y; Zou H; Strong JA; Cui Y; Xie Q; Zhao G; Jin M; Yu L
Eur J Pharmacol; 2006 May; 537(1-3):77-84. PubMed ID: 16626696
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms intrinsic to 5-HT2B receptor-induced potentiation of NMDA receptor responses in frog motoneurones.
Holohean AM; Hackman JC
Br J Pharmacol; 2004 Oct; 143(3):351-60. PubMed ID: 15339859
[TBL] [Abstract][Full Text] [Related]
19. Effects of a glycine transporter-1 inhibitor and D-serine on MK-801-induced immobility in the forced swimming test in rats.
Kawaura K; Koike H; Kinoshita K; Kambe D; Kaku A; Karasawa J; Chaki S; Hikichi H
Behav Brain Res; 2015 Feb; 278():186-92. PubMed ID: 25300471
[TBL] [Abstract][Full Text] [Related]
20. N-methyl-D-aspartate antagonist activity of alpha- and beta-sulfallorphans.
Shukla VK; Lemaire S
J Pharmacol Exp Ther; 1997 Jan; 280(1):357-65. PubMed ID: 8996216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
